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Recent reports of cytosine methylation occurring at CpA and CpT dinucleotides in murine ES cells as well as in Drosophila
have renewed interest in methylation at sites other than CpGs. Our examination of the murine neurofibromatosis type 1
gene by sodium bisulfite genomic sequencing has revealed non-CpG methylation primarily in the oocyte and the maternally
derived allele of the 2-cell embryo, with markedly lower levels found in sperm. Non-CpG methylation was not found in later
stages of embryo development or in adult tissue. Our results suggest that maternal-specific de novo non-CpG methylation
has occurred sometime between ovulation and formation of the 2-cell embryo, while during the same period the paternally
derived allele has undergone site-specific active demethylation. Our data demonstrate both stage and parent-of-origin
specific changes in methylation patterns within the neurofibromatosis type 1 coding region-involving cytosines located at
both CpG and non-CpG dinucleotides. © 2001 Elsevier Science
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Cytosine methylation is a principal base modification of
the vertebrate genome. In adult tissues, multiple roles have
been assigned to cytosine methylation including its in-
volvement in X-chromosome inactivation, genomic im-
printing, and the inactivation of retroviral sequences (Razin
and Riggs, 1980; Razin and Kafri, 1994; Walsh and Bestor,
1999). It is also apparent that cytosine methylation plays a
profound role in transcriptional repression of gene expres-
sion (Jones et al., 1998; Nan et al., 1998; Singal and Ginder,
1999). However, an important consequence of constitutive
CpG methylation is an increased risk for mutations result-
ing from deamination of 5-methylcytosine and the conse-
quent transition from C to T in coding regions (Laird and
Jaenisch, 1994; Yang et al., 1996; Rodenhiser et al., 1997).
Despite this potential mutational burden, vertebrates and
most other organisms with large genomes maintain an
active system of de novo and maintenance methylation as
well as an active system of demethylation (Jost, 1996;
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number of reports have clearly shown that established
patterns of methylation are critically important for normal
mammalian development (Li et al., 1992; Tate et al., 1996;
Okano et al., 1999).
The CpG dinucleotide is the preferred site of methylation
in adult tissues and it has long been assumed that
5-methylcytosines are found exclusively within CpG
dinucleotides. However, early reports in the literature using
nearest neighbor analysis revealed the presence of methyl-
ation at CpA and CpT dinucleotides (Salomon and Kaye,
1970; Grafstrom et al., 1985; Nyce et al., 1986; Woodcock et
al., 1987) but these findings were not followed up until
recently in two separate studies. The first report demon-
strated non-CpG methylation (occurring at both CpA and
CpT dinucleotides) in cultured murine ES cells (Ramsahoye
et al., 2000), while the second report demonstrated non-
CpG methylation during early development of Drosophila
melanogaster (Lyko et al., 2000). This latter finding is
particularly interesting since the genome of the adult fly
does not appear to contain 5-methylcytosine, although
during early development Drosophila express a protein
(DMNT2) that possesses a methyltransferase catalytic do-
main common to the family of DNA methyltransferases
(Hung et al., 1999). Functional characterization of DNMT2
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and Bestor, 1998) but in light of recent findings, DNMT2
has been postulated to be involved in the methylation of
non-CpG cytosines (Lyko et al., 2000). In addition, Ramsa-
hoye et al. have demonstrated that the de novo methyl-
transferase DNMT3a is also a strong candidate for non-CpG
methylase activity (Ramsahoye et al., 2000).
The dynamics of cytosine methylation during early mam-
malian development were first examined in detail by Monk
et al. (1987). Examination of total genomic methylation
revealed higher levels of methylation in the sperm genome
than in the oocyte. The initial work by Monk and cowork-
ers set the stage for more detailed analysis of differential
gametic and embryonic methylation profiles (Monk et al.,
1987; Howlett and Reik, 1991; Kafri et al., 1992; 1993;
McDonald et al., 1998; Warnecke et al., 1998). In 1992,
Kafri and co-workers used a PCR-based approach to show
that site-specific differences in methylation exist between
sperm and oocyte, and that the embryonic demethylation of
differentially methylated sites occurs more rapidly than for
sites that are mutually methylated in both sperm and
oocyte (Kafri et al., 1992). Recently it has been shown that
the paternal genome of the 1-cell mouse zygote undergoes
active demethylation immediately following fertilization
and prior to the first round of DNA replication (Oswald et
al., 2000; Mayer et al., 2000). The dynamic patterns of
methylation observed in the fertilized zygote are short lived
as eventually almost all gametic methylation is erased by
the time the embryo begins the process of compaction
during blastula formation (Monk et al., 1987; Kafri et al.,
1993). Those sites that escape demethylation, thus retain-
ing the gametic patterns of methylation, may be required as
landmarks for proper remethylation of imprinted genes
(Brandeis et al., 1993; Surani, 1998). It is generally believed
that global remethylation of the embryonic genome occurs
after implantation of the embryo, followed by gene-specific
demethylation events associated with transcriptional acti-
vation according to a specific developmental program
(Wolffe and Matzke, 1999; Turker, 1999).
Parent-of-origin effects observed in de novo mutagenesis
at the human neurofibromatosis type 1 (NF1) gene locus
(Jadayel et al., 1990; Stephens et al., 1992), have led us to
examine methylation patterns of the highly homologous
murine Nf1 gene both in gametes as well as at the earliest
stages of preimplantation development. Point mutations or
small insertions and deletions, which form the majority of
de novo NF1 mutations, have been shown to be primarily of
paternal origin, while the less common larger de novo
deletion events inactivating the NF1 gene are frequently
maternally derived (Lazaro et al., 1996; Ainsworth et al.,
1997). The initial goal of our study was to evaluate the
methylation status of a CpG dinucleotide within the mu-
rine Nf1 gene that correlates with a site of recurrent
mutation (C5839T) in exon 31 of the human NF1 gene
(Ainsworth et al., 1993; Andrews et al., 1996). Using our
model system, we have found that the murine equivalent of
© 2001 Elsevier Science. Athe human exon 31 CpG mutation site (C5839T) was fully
methylated in sperm, oocyte and the fertilized embryo up to
the 2-cell stage, with no allele-specific bias being seen.
Partial demethylation of this homologous CpG site became
apparent at the 4-cell stage, while by the 8-cell stage the
embryos showed methylation restricted exclusively to the
exon 31 site of recurrent mutation.
In the course of our experiments we have also discovered
an unexpected allele-specific non-CpG methylation at the
Nf1 locus. This non-CpG methylation, which was found
primarily at CpA dinucleotides and to a lesser extent at
CpTs, was seen both in mature oocyte DNA as well as
specifically on the maternal allele of the 2-cell embryo.
This pattern of non-CpG methylation was not found to any
appreciable extent in the sperm DNA or on the paternally
derived allele of the 2-cell embryo. Both the CpG and
non-CpG methylation we observed in the earliest stages of
embryogenesis had virtually disappeared by the 8-cell stage
of development. As well, our examination of the murine
adenosine deaminase gene (ADA) also demonstrated embry-
onic non-CpG methylation at the 2-cell stage of develop-
ment, though this gene locus does not show significant
non-CpG methylation in DNA from oocyte or sperm. These
results suggest that non-CpG methylation may represent a
more widespread event in the 2-cell embryo and appears to
arise as a result of de novo methylation in the earliest stages
of embryogenesis. These findings have led us to postulate
that the observed maternal-specific patterns of methylation
may play an important role in the development of the
embryo prior to implantation.
MATERIALS AND METHODS
Identification and Sequencing of the Murine Nf1
Intron 31
Sequence identity between the human NF1 and mouse Nf1
cDNA sequences was used to delineate the exonic configuration of
the murine version of the Nf1 gene. PCR primers for the murine
gene were determined using the mouse cDNA sequence (accession
number L10370.1). The forward primer (20–168) was determined
from a region having high sequence identity with exon 31 of the
human NF1 gene (accession numbers L05367, L03723). The reverse
primer (20–169) was chosen which matched the sequence from
exon 32 of human NF1. When these primers were used in the PCR
with genomic mouse DNA a single 1033 bp product was obtained.
Reaction conditions were 30 cycles (94oC for 80 s; 60oC for 120 s;
72oC for 120 s). The resulting product contained an intervening
sequence of 723 bp (accession number AY026046). The DNA
sequence of this was shown to possess the essential consensus
sequences found at mammalian intron/exon boundaries. There-
fore, we have concluded that this sequence represents the genomic
sequence of the murine Nf1 gene.
PCR Primers
Nf1 exon 31: (20–168) 59 CCTTTGTTTGGAATATATGACCCC 39
Nf1 exon 32: (20–169) 59 CACCAATTTCACATTTCCAGAAGC 39
ll rights reserved.
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CAAAATACTC 39
Nf1 SF nested: (20–215) 59 ATTTTTGTTTGGAATATATGATTT-
TATGG 39
Mus musculus SR: (20–311) 59 CAACTATACATACAAACAAA-
TATTATAAATAAC 39
Mus spretus SR: (20–312) 59 TACATATTCTATATAAACTATACA-
TATTC 39
Nf1 SF external: (220–125) 59 GTATTGAATTGAAGTATTTTGTT-
TGG 39
Nf1 SR external: (220–126) 59 CAATCAATCAAAAAAATAACTC-
CAAAACC 39
ADA SF external: (20–621) 59 TGTTTTGAGTGAGTTTTTGTA-
AGG 39
ADA SR external: (20–622) 59 AACTACTATTCAAATCACACTCC 39
ADA SF internal: (20–632) 59 TTAAGTTTTTTTTTAGAGGAA-
GAG 39
ADA SR internal: (20–633) 59 ATTTTTTCAAAACTATCCCT-
ACTC 39
The ADA primers were written from DNA sequence obtained
from GenBank (accession number U73107). The external primers
amplify the sense strand of sodium bisulfite converted DNA from
nt 26723 to 27236.
Collection of Tissues and DNA Isolation/
Preparation
Sperm was collected from the testis and epididymis of
(C75BL6xCBA) F1 males and subjected to an extended (64 h)
proteinase K digestion (20 ug/ml added each 24 h) in standard lysis
buffer (10 mM Tris-HCL, 10 mM EDTA, 1% SDS). Sperm DNA was
then isolated by phenol/chloroform and washed in 70% ETOH, air
dried, and resuspended in ddH2O.
Oocytes were collected from CD1 mice superovulated by inter-
peritoneal injection of 5 i.u. (international units) of pregnant mare
serum (PMS) followed 48 h later by 5 i.u. of human chorionic
gonadotropin (HCG). Eggs were collected 12 h post-HCG and
treated with hyaluronidase in 1X PBS for 5 min to remove any
remaining cumulus cells, then briefly washed in acidic Tyrodes
solution to dissolve the zona pellucida. Eggs were then repeatedly
washed in 1X PBS containing 1% bovine serum albumin (BSA).
Approximately 40–50 oocytes were pooled and digested at 55°C for
48 h in standard lysis buffer containing proteinase K. Aliquots of
the digested slurry were heated to 95°C for 5 min then incubated in
0.2M NaOH for 10 min at 70°C to fully denature the DNA. This
mixture was immediately mixed with 2 volumes of 2% low melt
point (LMP) agarose preheated to 80°C so that 10 ml beads could be
formed by pipetting the DNA/agarose mixture directly into ice cold
mineral oil.
Approximately 30–40 embryos were collected at the 2-, 4-, and
8-cell stages at 36, 60, and 72 h post-HCG from superovulated CD1
females mated with (C57BL6xCBA) F1 males. All embryos were
washed in 1X PBS with 1% BSA and pooled for proteinase K
digestion as above. Compacted morulae and blastocysts were
flushed from the uterus at 90 h post-HCG and prepared as above.
7.5 dpc egg cylinders were obtained from CD1 females crossed as
described above and dissected to remove extraembryonic compo-
nents. Embryos at 10.5 dpc were isolated from CD1 females crossed
as above and were used in whole for DNA extraction. The adult
tissues examined were from tail clips of (C57BL6xCBA) F1 mice.
DNA was purified from 7.5 dpc, 10.5 dpc embryos, and adults by
© 2001 Elsevier Science. AProteinase K digestion in lysis buffer (as above) followed by
phenol/chloroform extraction.
Interspecific Mouse Crosses (Mus spretus 3 Mus
musculus)
We sequenced a number of inbred and wild-derived inbred
mouse strains for informative polymorphic markers and identified
a 23 bp insertion within Nf1 intron 31 in DNA from the wild-
derived strain Mus spretus (Fig. 1). Hybrid crosses between Mus
spretus and Mus musculus were used to generate hybrid 2-cell
embryos. Matings were set up using (C57BL6xCBA) F1 females and
Mus spretus males. The 23 bp sequence polymorphism within
intron 31 allowed for allele-specific PCR amplification of the
maternal and paternal alleles using strain-specific PCR primers.
First round PCR primers (220–125) and (220–126) were positioned
outside the polymorphic region to allow amplification from both
maternal and paternal alleles in hybrid embryos. The second round
reverse primers were specific to either Mus spretus (20–312) or Mus
musculus (20–311) DNA sequences. These primers were used in
separate reactions resulting in the strain-specific amplification and
isolation of maternal and paternal alleles. This method allowed for
the unbiased amplification of both alleles while greatly increasing
the efficiency of the cloning reactions by eliminating the compli-
cations of cloning heteroduplexed PCR product.
Methylation Analysis by Sodium Bisulfite
Sequencing
Samples of phenol/chloroform purified genomic DNA were
treated with sodium bisulfite as initially described by Clark et
al. (1994). Briefly, approximately 0.5–2.0 ug of DNA was dena-
tured in 0.3M NaOH, then incubated at 55°C in 5.0M sodium
bisulfite and 10mM hydroquinone for 16 h and followed by
desalting and desulfonation in 0.2M NaOH. The bisulfite treated
DNA was then precipitated with ethanol and resuspended in
ddH2O. The picomolar quantities of gametic and embryonic
genomic DNA were treated with sodium bisulfite as described in
Olek et al. (1996). Picomolar amounts of DNA were immobi-
lized in LMP agarose for the sodium bisulfite conversion and
desulfonation. Following a series of washes in 1X TE and ddH2O
the agarose beads were then used directly for PCR with the
appropriate primers. We have found that sodium bisulfite con-
version in agarose beads does not alter the efficiency of conver-
sion but rather acts only to minimize the loss of sample since no
DNA isolation steps are required following the bisulfite conver-
sion reactions. First round PCR for all bisulfite-converted
samples was performed using Nf1 external primers (220 –125)
and (220 –126). The second round PCR for the CD1 and
(C57BL6xCBA) F1 mice was performed using the Nf1 internal
primers (20 –214) and (20 –215). All second round nested PCR
was carried out using the diluted (10X) first round product as
template. PCR primers for bisulfite converted sequences were
written to amplify the sense strand of the converted product.
Treatment of DNA by sodium bisulfite and the subsequent
desulfonation reaction in NaOH results in the deamination of
unmethylated cytosines forming a uracil residue and thus a U:G
mispair (Clark et al.,1994). Primers for our experiments were
designed to anneal to the converted sense strand and extend back
to create a new antisense template complementary to the
converted sense strand. The sense forward primer is designed to
anneal to this newly synthesized strand. Prolonged annealing
ll rights reserved.
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efficient copying of the converted sense strand. This is done to
minimize the chances of introducing a sampling bias by not
having the large majority of sense strand templates primed and
extended in the first few critical rounds of the PCR. Conceivably
PCR bias could result if the sense reverse primers were to have
a 39end that corresponds to a base that is altered by the sodium
bisulfite treatment. This would result in a primer extension
block on converted templates and would greatly favor amplifi-
cation from any templates that were not fully converted. We
have addressed this potential problem by designing all of the
sense reverse primers to end in a cytosine residue. This ensures
that extension from the 39end would not have been blocked
since the corresponding base on the converted sense strand will
be a guanine that is not altered in the sodium bisulfite reactions.
All PCR products were cloned into the pCR II vector using the
FIG. 1. Illustration of the murine Nf1 region studied noting the
sequences within the intervening sequence labeled as intron 31
homology to the human NF1 genomic sequence (see Methods
indicating direction (59 to 39) relative to the sense stand. Diagr
sequence illustration. Circles represent CpG dinucleotides, squa
are not shown in any figure since they were never found to be me
representations. The larger PCR products contain more of the 39
and Mus musculus (20 –311) specific primers. DNA sequence al
is shown in the expanded diagram below the sequence illustrat
within the polymorphic region of intron 31.TOPO TA Cloning Kit (Invitrogen) and manually sequenced using
© 2001 Elsevier Science. Athe T7 polymerase Sequencing Kit (Amersham). The Nf1 SF nested
primer (20–215) was used for manual sequencing of cloned PCR
products. Sequencing reactions were run on 6% denaturing poly-
acrylamide gels, dried and exposed to Biomax MR film for 24 h.
RESULTS
Identification and Sequencing of the Murine Nf1
Intron 31
The region of the murine Nf1 gene identified for study is
illustrated in Fig. 1. We determined the genomic sequence
of this region using primers (20–168) and (20–169) which
are common to both the human NF1 and mouse Nf1 cDNA
sequences, and which yielded a single 1033 bp PCR product.
tion and orientation of PCR primers as well as the polymorphic
xes delineate mouse Nf1 exons 31 and 32 inferred by sequence
ll accession numbers). PCR primers are numbered with arrows
atic representations of the PCR products are shown above the
present CpAs, and triangles represent CpTs. CpC dinucleotides
ated. Cytosines of interest are numbered above the PCR product
nic sequence and were generated using the Mus spretus (20 –312)
ent of the polymorphic region of the Nf1 intervening sequence
Arrows mark the placement of the strain-specific PCR primersloca
. Bo
for a
amm
res re
thyl
intro
ignm
ion.This product contained an intervening sequence of 723 bp
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revealed typical exon-intron boundary consensus sequences
and we concluded that this PCR product represented the
murine Nf1 genomic sequence homologous to the human
NF1 exon 31/intron 31/exon 32 genomic sequence.
Non-CpG Methylation at the Nf1 Locus in 2-cell
Embryos
Our initial methylation analysis by sodium bisulfite se-
quencing of the Nf1 gene in 2-cell embryos from
CD1x(C57BL6xCBA) F1 mice revealed a roughly 1:1 ratio of
clones that showed non-CpG methylation to those that did
not, which strongly suggested a parent-of-origin effect (Fig. 2).
For the first round of PCR, primers (220–125) and (220–126)
were used for amplification of sodium bisulfite treated 2-cell
embryos embedded in low melt point agarose beads. In a
second round of PCR, primers (20–215) and (20–214) were
used to amplify a fragment of 284 bp (spanning the exon
31/intron 31 junction) that contains 30 cytosines of interest
within CpG, CpA, and CpT dinucleotides as illustrated in Fig.
1. No CpC dinucleotides were found to be methylated, there-
fore their locations are not shown in the diagram. All clones
shown in Fig. 2 are from the 284 bp nested PCR products
generated using primers (20–214) and (20–215). Our data
demonstrates that the 40 clones examined segregate roughly
1:1 into two groups, one having both CpG and non-CpG
methylation and the other showing only CpG methylation or
no methylation at all. The distribution of methylation pat-
terns in two distinct groups was suggestive of an (allele-
specific) parent-of-origin effect.
Experiments were then set up to evaluate the parent-of-
origin of the Nf1 alleles in 2-cell embryos. We utilized
hybrid crosses between Mus musculus and the wild derived
strain Mus spretus to identify maternal and paternal Nf1
alleles. Our sequence analysis of the wild-derived strain
Mus spretus revealed a 23 bp insertion within intron 31 of
the murine Nf1 gene as illustrated in Fig. 1. This polymor-
phism allowed for allele-specific PCR amplification of the
maternal and paternal alleles using strain-specific PCR
primers. First round PCR primers (220–125) and (220–126)
were positioned outside the polymorphic region to allow
amplification from both maternal and paternal alleles in
hybrid embryos. The second round reverse primers were
specific to either Mus spretus (20–312) or Mus musculus
(20–311) DNA sequences. These primers were used in
separate reactions resulting in strain-specific amplification
and isolation of maternal or paternal Nf1 alleles. The Mus
spretus specific PCR used primers (20–215) and (20–312)
amplified a single product of 485 bp, while the Mus mus-
culus PCR primers (20–215) and (20–311) amplified a single
product of 481 bp. Both sequences contain 52 cytosines of
interest, including 22 sites additional to the 30 that are
present in the 284 bp product. Strain specificity of these
primers was confirmed during the optimization of the PCR
© 2001 Elsevier Science. Aconditions where the Mus spretus specific primers showed
no amplification with Mus musculus DNA templates, and
FIG. 2. Methylation profiles of all Nf1 gene clones by sodium
bisulfite sequencing of genomic DNA derived from 2-cell embryos
obtained from crosses between CD1 females and (C57BL6xCBA) F1
males. The illustrations represent sequences from the exon 31/intron
31 region of the murine Nf1 gene shown in Fig. 1. The Nf1 SF nested
primer (20–215) was used for manual sequencing of cloned PCR
products. Circles represent CpG dinucleotides, squares represent
CpAs, and triangles represent CpTs. Solid symbols denote methylated
cytosines; open symbols denote unmethylated cytosines. All clones
are from the 284 bp nested PCR products generated using primers
(20–214) and (20–215). The clones are in two sets of 20 clones that
were obtained from two separate experiments using identical condi-
tions. The clones segregate roughly 1:1 into two groups, one having
both CpG and non-CpG methylation and the other showing only CpG
methylation or no methylation at all.vice versa (data not shown).
ll rights reserved.
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591Allele-Specific, Non-CpG MethylationSodium Bisulfite Sequencing of the Nf1 Locus in
Gametes and 2-Cell Hybrid Embryos
Fig. 3 shows the methylation profiles of clones from
sodium bisulfite converted samples of oocyte, sperm, and
both alleles of the 2-cell hybrid embryo. The methylation
profiles of the sperm and oocyte differ both in the location
and degree of non-CpG methylation. Fig. 3a shows that all
oocyte clones demonstrate the presence of non-CpG meth-
ylation occurring primarily at CpA dinucleotides at posi-
tions 2, 18 and 28. Fig. 3b illustrates that clones from sperm
show few sites of non-CpG methylation with the vast
majority of methylated cytosines occurring at the CpG
dinucleotides. All clones from sperm are methylated at the
first CpG dinucleotide in position 1, while 17 of 20 clones
are methylated at the second CpG at position 9. All clones
examined from oocytes showed methylation of the CpG
dinucleotides at positions 1 and 9. Table 1 shows that the
methylation profiles of sperm and oocyte differ primarily in
the degree of non-CpG methylation but show similar levels
of CpG methylation at the Nf1 locus. Sperm DNA con-
tained 1.8% non-CpG methylation, while oocyte contained
11.6%. Sperm and oocyte contain similar levels of CpG
TABLE 1
Developmental stage Gene/allele Number of clones %
Oocyte Nf1 20
Sperm Nf1 20
2-cell (hybrid) Nf1 (maternal) 9
2-cell (hybrid) Nf1 (paternal) 9
2-cell Nf1 40
4-cell Nf1 20
8-cell Nf1 20
7.5 day Nf1 20
10.5 day Nf1 19
Oocyte ADA 22
Sperm ADA 20
2-cell ADA 27
FIG. 3. Methylation profiles of all Nf1 gene clones by sodium bi
maternal and 2-cell paternal alleles. The illustrations represent sequ
in Fig. 1. The Nf1 SF nested primer (20–215) was used for manual se
squares represent CpAs, and triangles represent CpTs. Solid symb
cytosines. (a) Oocyte and (b) sperm clones are from the 284 bp neste
DNA was obtained from CD1 females. Sperm DNA was derived
methylation at positions 1 and 9. Non-CpG methylation is seen p
occurs primarily at CpGs in positions 1 and 9. Isolation of the ma
achieved by allele-specific PCR from hybrid embryos generated b
(C57BL6xCBA) F1 females. The Mus spretus specific (paternal) PCR
bp and the Mus musculus (maternal) PCR using primers (20–215) an
52 cytosines of interest, including 22 additional 59 sites added to t
the 2-cell embryo is heavily methylated at both CpGs (positions 1,
50). The paternal allele of the 2-cell embryo shows CpG methylation p
© 2001 Elsevier Science. Amethylation, calculated to be 93% and 100%, respectively
(Table 1).
Clones from allele-specific PCR products amplified from
2-cell Mus spretus x Mus musculus hybrid embryos show
strikingly different patterns of methylation (Figs. 3c,d).
Clones from the maternally derived Nf1 allele are heavily
methylated at both CpG and non-CpG sites, in contrast to
the clones of paternal origin, which have maintained meth-
ylation only at the CpG site in position 1. The degree of
CpG methylation in the 2-cell hybrid embryo was 100% for
the maternal Nf1 allele and 33.3% for the paternal Nf1
allele. The maternal Nf1 allele also showed much higher
levels of methylation at CpA dinucleotides, with 35.2% of
these site being methylated compared to 0% for the pater-
nal Nf1 allele. CpT methylation was 6.0% for the maternal
Nf1 allele and 0.8% for the paternal Nf1 allele in the 2-cell
hybrid embryo (Table 1). Fig. 3 shows the site specificity of
methylation in this region of the Nf1 gene. There are nine
sites that were found to be methylated in all clones from
the 2-cell maternal PCR product. Three are methylated
CpGs at positions 1, 9, and 52, while five are methylated
CpAs at positions 18, 20, 28, 30, and 41. The remaining site
ethylation CpG % Methylation CpA % Methylation CpT
100.0 21.4 1.8
93.0 0.7 2.9
100.0 35.2 6.0
33.3 0 0.8
61.3 14.1 4.5
45.0 3.2 0
47.5 0.4 0
82.5 0.38 0
94.7 0.38 0
60.0 0 0.2
100.0 0 0
60.7 2.8 0.18
e sequencing of genomic DNA derived from oocyte, sperm, 2-cell
s from the exon 31/intron 31 region of the murine Nf1 gene shown
cing of cloned PCR products. Circles represent CpG dinucleotides,
enote methylated cytosines; open symbols denote unmethylated
R products generated using primers (20–214) and (20–215). Oocyte
(C57BL6xCBA) F1 males. Clones from oocyte demonstrate CpG
ily at CpAs in positions 2,18 and 28. Methylation of sperm DNA
al (c) and paternal (d) Nf1 alleles from 2-cell mouse embryos was
erspecific crosses between Mus spretus males and Mus musculus
g primers (20–215) and (20–312) amplified a single product of 485
–311) amplified a single product of 481 bp. Both sequences contain
that are present in the 59 284 bp product. The maternal allele of
52) and non-CpGs (positions 18, 20, 22, 27, 28, 30, 36, 41, 45, andMsulfit
ence
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9 andrimarily at position 1.
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was not observed in any CpC dinucleotide, therefore CpCs
are not shown in the illustrations or included in the
percentage methylation calculations presented in table 1.
Seven of the nine clones from the maternal-specific PCR
product show unique patterns of methylation, while only
two of the clones exhibit an identical methylation pattern,
confirming that the maternal-specific PCR has represented
at least seven different DNA molecules, which suggested a
PCR with low bias that did not result in the over represen-
tation of any single template.
A comparison of the methylation pattern of the 2-cell
embryo (Fig. 2) and the oocyte DNA (Fig. 3a) demonstrated
an increase in the number of non-CpG sites methylated
between the oocyte stage and the 2-cell embryo. The
additional sites methylated are CpAs at positions 20 and 22,
suggesting that methylation had occurred de novo between
the period of oocyte release and the 2-cell stage of embryo-
genesis. Furthermore the CpA sites at positions 2 and 28 are
found fully methylated in oocyte (Fig. 3a) and are not found
to be methylated in the 2-cell data presented in Fig. 2. These
observations demonstrate that site-specific variation exists
for non-CpG methylation that is likely the result of a highly
dynamic process of non-CpG methylation during oogenesis
and early development.
Our data also suggest that the paternally-derived Nf1
allele of the 2-cell hybrid embryo is actively demethylated
sometime between fertilization and the formation of the
2-cell embryo. This is evident when the clones from sperm
are compared with those from the paternal allele in the
2-cell hybrid embryo (Fig. 4b,d). Site-specific demethylation
of the paternal Nf1 allele at the CpG site in position 9 is
demonstrated in all clones of the 2-cell hybrid embryo. It
would appear that this results from an active process, since
the persistence of methylation at position 1 on the paternal
allele of the 2-cell embryo is not consistent with a mecha-
nism of passive demethylation.
Sodium Bisulfite Sequencing of the Nf1 Locus in
Pre and Postimplantation Embryos
The 4-cell, 8-cell, 16–32 cell (blastula), 7.5 day and 10.5
day embryos were obtained from matings of CD1 females
and (C57BL6xCBA) F1 males. Clones from the 4-cell stage
embryos show a reduction in levels of both CpG and
non-CpG methylation (Fig. 4). The degree of non-CpG
methylation in the 4-cell embryo, with 9 of 20 clones
showing low levels of non-CpG methylation, (3.2%) (Fig. 4a
and Table 1) is reduced from the levels found on the
maternal allele at the 2-cell stage (35.2%) (Fig. 3c and Table
1). When the methylation patterns of maternal-specific
clones of the 2-cell embryo (Fig. 3c and Table 1) (where the
highest levels of non-CpG methylation are found) are com-
pared with the patterns observed for the 4-cell embryos (Fig.
4a and Table 1), it is apparent that a drastic reduction in
methylation has occurred between the 2-cell and 4-cell
stages of embryogenesis.
© 2001 Elsevier Science. AThe 8-cell embryo (Fig. 4b) demonstrates a pattern of
methylation that is similar to that found on the paternal
allele of the 2-cell embryo (Fig. 3 days) where the only site
to be consistently methylated is the CpG at position 1.
Interestingly this site corresponds to the site of recurrent
mutation (C5839T) in the human NF1 gene. Nearly all
clones (19/20) from the 8-cell stage embryos were methyl-
ated at position 1 while only (9/20) were methylated at this
site in the 4-cell embryo. Subsequently an apparent de-
methylation event occurring sometime during the forma-
tion of the blastula (16–32 cell stage) results in the com-
plete elimination of all methylated cytosines (at both CpG
and non-CpGs) in all clones examined at this stage of
development (data not shown). These data are consistent
with the literature where genome-wide demethylation is
seen at this stage of murine development (Monk et al.,
1987; Kafri et al., 1993). The remethylation events occur-
ring sometime postimplantation resulted in the 7.5 day and
10.5 day embryos (Fig. 4) both sharing the adult pattern of
CpG methylation at positions 1 and 9. The postimplanta-
tion methylation patterns at this region of the Nf1 gene
appear to stabilize and do not include non-CpG sites at any
appreciable levels. Our results show that non-CpG methyl-
ation found at the murine Nf1 locus is limited primarily to
the oocyte and the maternal allele of the 2-cell embryo and
does not persist in later stages of development or postna-
tally.
Sodium Bisulfite Sequencing of the Adenosine
Deaminase (ADA) Gene in Gametes
and 2-Cell Embryos
The ADA gene was chosen arbitrarily for methylation
analysis by sodium bisulfite sequencing. Nested primers
specific for the sense strand of sodium bisulfite treated
DNA were used to amplify a region of the ADA gene
including the 39portion of exon 11 and most intron 11 (nts
26850 to 27221, accession number U73107). Sperm DNA
showed 100% methylation at CpGs while oocyte DNA
showed 60% CpG methylation (Table 1). In addition the
gametes show site-specific patterns of methylation with
sperm DNA being specifically methylated at sites 1 and 24,
while both sperm and oocyte are methylated at sites 10,11,
and 13 (Fig. 5). Non-CpG methylation was not found in
sperm and appeared at only a single CpT site in one clone
from oocyte within the ADA sequence examined (Fig. 5).
This is in contrast to the Nf1 locus where oocyte DNA was
found to have 11.6% non-CpG methylation (Table 1).
Non-CpG methylation of the ADA gene was observed in
4 of the 27 clones examined while CpG methylation was
found in 19 of 27 clones (Fig. 5). The remaining 8 clones
showed no cytosine methylation. The 2-cell embryos di-
verse patterns of methylation reflect the dynamic process of
methylation and demethylation occurring in the very early
embryo. The presence of non-CpG methylation within the
ADA gene, albeit at lower levels than Nf1, suggest that this
phenomenon may be wide spread throughout the genome.
ll rights reserved.
593Allele-Specific, Non-CpG MethylationFIG. 4. Methylation profiles of all Nf1 gene clones by sodium bisulfite sequencing of genomic DNA derived from 4-cell, 8-cell, 7.5 day,
and 10.5 day mouse embryos. All embryonic tissues are from CD1 x (C57BL6xCBA) F1 mice. The illustrations represent sequences from
the exon 31/intron 31 region of the murine Nf1 gene shown in Fig. 1. The Nf1 SF nested primer (20–215) was used for manual sequencing
of cloned PCR products. Clones of all samples are from PCR products (284 bp) generated using primers (20–214) and (20–215). (a) 4-cell
embryo, (b) 8-cell embryo, (c) 7.5 day, and (d) 10.5 day embryo. Circles represent CpG dinucleotides, squares represent CpAs, and triangles
represent CpTs. Solid symbols denote methylated cytosines; open symbols denote unmethylated cytosines. The 4-cell embryo demon-
strates erratic patterns of both CpG and non-CpG methylation. The 8-cell embryo is methylated primarily at the CpG in position 1. The
7.5 day and 10.5 day embryo both demonstrate CpG methylation at positions 1 and 9.
© 2001 Elsevier Science. All rights reserved.
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Parent-of-origin effects observed in patterns of de novo
mutation at the human NF1 gene locus led us to suggest
that differential patterns of allele-specific cytosine methyl-
ation, either in the gamete or at the earliest stages of
embryogenesis may be responsible for this effect. The
initial goal of this study was to evaluate the methylation
status of a CpG dinucleotide within exon 31 of the Nf1
gene. This site correlates with a site of recurrent de novo
mutation in exon 31 (C5839T) of the human NF1 homo-
logue (Ainsworth et al., 1993; Andrews et al., 1996). Previ-
ous work has demonstrated that there is an allele-specific
de novo mutation bias at the NF1 locus where the majority
of point mutations are of paternal origin while large dele-
tion events are primarily of maternal origin (Lazaro et al.,
1996; Ainsworth et al., 1997). Prompted by these observa-
tions we established a murine model to examine the meth-
ylation status of the Nf1 coding region in gametes and
preimplantation embryos by sodium bisulfite genomic se-
quencing. This technique allows for the identification of all
methylated cytosines along a continuous DNA sequence.
We first showed that the CpG dinucleotide representing
the murine equivalent of the human exon 31 mutation site
was fully methylated in both sperm and oocyte, and showed
no appreciable allelic bias (Fig. 3). What was unexpected
was the discovery of non-CpG methylation, which was
found to be present in the oocyte but was not observed in
sperm. Further methylation analysis of this region of the
Nf1 gene in 2-cell embryos from CD1 mice revealed that
roughly half of the allelic clones showed non-CpG methyl-
ation, which suggested a possible parent-of-origin effect.
This latter was confirmed by allele-specific bisulfite se-
quencing of the murine Nf1 gene in 2-cell stage embryos
generated from interspecific crosses between Mus spretus
and Mus musculus which demonstrated high levels of
non-CpG methylation on the maternally-derived allele. In
contrast, the paternally-derived allele of the 2-cell embryo
showed only very low levels of non-CpG methylation
indicating that non-CpG methylation was primarily lim-
ited to the maternal allele at the Nf1 locus (Fig. 3c,d). When
the methylation profiles of DNA from CD1 oocytes (Fig. 3a)
were compared with those of the CD1 female x F1 male
2-cell embryo (Fig. 2), it was observed that additional CpA
sites were methylated in the 2-cell embryo, suggesting that
FIG. 5. Methylation profiles of all adenosine deaminase (ADA) gen
oocyte, sperm, 2-cell embryos. The illustrations represent sequence
number U73107). The ADA SF nested primer (20–632) was used f
dinucleotides, squares represent CpAs, and triangles represent Cp
unmethylated cytosines. Oocyte DNA was obtained from F1(C57
males. Clones from oocyte demonstrate CpG methylation at positi
in positions 1,10,11,13 and 24. 2-cell embryos were obtained from
dynamic pattern of methylation with 4 of 27 clones showing non
methylation was found in 19 of 27 clones, with the remaining 8 clones
© 2001 Elsevier Science. Ade novo non-CpG methylation had occurred on the mater-
nal allele in the interval between ovulation and the forma-
tion of the 2-cell embryo. In addition the comparison of
clones from different sample groups from the 2-cell embryo
(Figs. 2 and 3c) show site-specific variation for non-CpG
methylation. It is possible that these differences may arise
from a dynamic process of methylation during oogenesis
and early development. Such plasticity in the establish-
ment or maintenance of non-CpG methylation could also
account for the sequence-specific variations between the
oocyte and the 2-cell stage.
The patterns of CpG methylation observed in sperm and
on the paternal allele of the 2-cell mouse embryo support
recent findings of active demethylation occurring on the
paternal allele in the 1-cell mouse embryo. We found that a
particular CpG site (marked as position 1; Fig. 1) was
methylated in both the sperm and the paternal allele of the
2-cell embryo, while a second CpG at position 9 was only
methylated in sperm and was not found to be methylated in
the paternal allele of the 2-cell embryo (Fig. 3b,d). These
data support work by Oswald and co-workers who have
recently shown that the paternal allele of Igf2 is actively
demethylated in the 1-cell zygote shortly following fertili-
zation while methylation on the maternal allele remained
constant or in some cases showed further de novo methyl-
ation (Oswald et al., 2000).
Our data obtained from bisulfite sequencing of 4- and
8-cell mouse embryos revealed that non-CpG methylation
did not persist beyond the 2-cell stage in any appreciable
levels. When the methylation patterns of maternal-specific
clones of the 2-cell embryo (where the highest levels of
non-CpG methylation are found) are compared with the
patterns observed for the 4-cell embryos, it is apparent that
a drastic reduction in both CpG and non-CpG methylation
has occurred. Clones from the 8-cell stage embryos demon-
strate an interesting pattern of methylation since the only
site to be consistently methylated is the CpG at position 1.
Recent studies have shown that non-CpG methylation
exists in cultured murine ES cells and evidence has been
presented suggesting that DNMT3a may be responsible for
the establishment of non-CpG methylation in these cul-
tured cells (Ramsahoye et al., 2000). It may be of value to
examine the expression patterns of DNMT3a in murine
gametes and the very early embryo to determine if
nes by sodium bisulfite sequencing of genomic DNA derived from
the exon 11/intron 11 region of the murine ADA gene (accession
anual sequencing of cloned PCR products. Circles represent CpG
olid symbols denote methylated cytosines; open symbols denote
CBA) females. Sperm DNA was derived from F1 (C57BL6xCBA)
0,11 and 13. Methylation of sperm DNA occurs primarily at CpGs
emales mated with F1 males. Clones from 2-cell embryos show a
methylation occurring at multiple CpA sites. Overall, cytosinee clo
s from
or m
Ts. S
BL6x
ons 1
F1 f
-CpGshowing no methylation.
ll rights reserved.
596 Haines, Rodenhiser, and AinsworthDNMT3a expression correlates with and precedes the es-
tablishment of non-CpG methylation in the 2-cell embryo.
An apparent global demethylation event at the blastula
stage resulted in complete demethylation of all cytosines in
all clones examined (data not shown). This is consistent
with the literature reporting genome wide demethylation at
this stage of murine development (Monk et al., 1987; Kafri
et al., 1992; 1993). The apparent re-establishment of meth-
ylation postimplantation resulted in the 7.5 day and 10.5
day embryos both sharing the adult pattern of CpG meth-
ylation with minimal levels of non-CpG methylation. This
adult pattern of CpG methylation is in stark contrast to the
complex patterns of methylation occurring at non-CpG
sites in the oocyte and 2-cell embryo but does not exclude
the possibility that residual genomic non-CpG methylation
may exist at low levels in adult tissues.
It would appear that non-CpG methylation may represent
a more widespread phenomenon in the earliest stages of
embryogenesis. Data from bisulfite sequencing of the aden-
osine deaminase gene (ADA) in 2-cell murine embryos has
shown non-CpG methylation in 4 of 27 clones examined
(2.8%) (Fig. 5c and Table 1) while CpG methylation was
seen in a little over one half (19 of 27) of the clones
examined. Taken together with our findings at the Nf1
locus, the roughly 1:1 pattern of clones that show methyl-
ation of the murine ADA gene suggests that methylation at
this gene locus may also be allele-specific in the 2-cell
embryo. Interestingly, the ADA sequence did not show
non-CpG methylation in the oocyte or sperm DNA. This is
in contrast to the Nf1 locus, which shows significant
non-CpG methylation in the oocyte samples. It is conceiv-
able that if these same patterns of gamete specific methyl-
ation are present at the human NF1 locus, these may be
related to the observed allele-specific mutation bias at the
NF1 locus.
It is not surprising that the early stages of development
would show the most dynamic patterns of cytosine meth-
ylation, when one considers the range of developmental
changes that take place from the point of fertilization until
the implantation of the embryo in the uterine wall. The
genetic contributions of the male and female gametes exist
in very different states of readiness. The genome of the
sperm, with histones replaced by basic protamines for
purposes of packaging, must now reverse the process and
restore the transcriptionally competent structure of DNA,
histones and the basal transcription machinery (Bench et
al., 1996). On the other hand, the female contribution has
not been handicapped by such drastic alterations in chro-
matin structure. To maintain an equivalent developmental
potential from both parental contributions it may be nec-
essary to temporarily repress transcription from the mater-
nal genome thus allowing the paternally derived DNA to be
restructured prior to the formation of the diploid zygotic
genome.
Studies examining transcriptional activation in the 1-cell
mouse zygote have demonstrated differential transcription
from paternal and maternal genomes. Reporter constructs
© 2001 Elsevier Science. Amicroinjected into male and female pronuclei have demon-
strated that only the male pronucleus showed expression in
G2 during the first cell cycle (Ram and Shultz, 1993).
Endogenous zygotic transcription has been examined by
measuring 5-bromouridine-59-triphosphate (BrUTP) incor-
poration into newly transcribed mRNAs. Results from two
separate studies have shown that the male pronucleus
consistently incorporates higher levels of BrUTP than does
the female pronucleus (Bouniol et al., 1995; Aoki et al.,
1997). The male pronucleus also contains higher levels of
the general transcription factor Sp1 and the TATA-binding
protein TBP than are present in the female pronucleus
(Worrad et al., 1994).
The link between transcriptional activation and chroma-
tin structure has been explored by the demonstration of
differential H4 acetylation on paternal versus maternal
chromatin at the pronuclear stage of the mouse zygote
(Adenot et al., 1997). It has been postulated that the
increased transcriptional activity found in the male pro-
nucleus is a result of both the overall levels and the
localization of acetylated H4, further lending support to the
concept of differential transcription of the paternal and
maternal genomes in the 1-cell zygote. (Adenot et al., 1997).
In light of the findings summarized above and our dem-
onstration of allele-specific methylation at the 2-cell stage,
it is conceivable that maternal-specific methylation may
play a role in allele-specific transcriptional activation in the
early preimplantation mouse embryo. The presence of high
levels of methylation on the maternally derived chromatin
may act as an impediment to transcriptional activation,
either directly by inhibiting binding of transcription factors
or more likely indirectly by altering the chromatin struc-
ture via histone deacetylation. Certainly the preferred bias
of larger chromosomal de novo human NF1 deletion events
to the maternally derived chromosome would be more
consistent with an allele-specific structural modification of
chromatin.
In conclusion, our examination of the murine Nf1 gene
has revealed non-CpG methylation both in the oocyte and
the maternally-derived allele of the 2-cell embryo, lending
support to the recent reports of cytosine methylation oc-
curring at CpA and CpT dinucleotides in murine ES cells
and in Drosophila. In addition, our data demonstrate both
stage- and parent-of-origin specific changes in non-CpG
methylation within the Nf1 coding region during early
mouse development, with additional data suggesting that
this may represent a more widespread phenomenon.
The study of cytosine methylation and the demonstra-
tion of its functional significance in mammalian develop-
ment remains an ongoing process. The finding of non-CpG
methylation during early embryogenesis adds another ele-
ment of complexity to current models of epigenetic control
and may prove to further underscore the importance of
cytosine methylation in mammalian development. The
demonstration of the molecular characteristics of non-CpG
methylation both in terms of its possible interactions with
ll rights reserved.
597Allele-Specific, Non-CpG MethylationDNA binding proteins and possible effects on chromatin
structure will merit further study.
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